Morgan Stanley analyst Toni Kaplan lowered the firm’s price target on BrightView (BV) to $12 from $16 and keeps an Equal Weight rating on the shares after its Q4 earnings miss and below-consensus guidance. The company continued to be impacted by macro-induced maintenance and development headwinds as revenue missed estimates, although margin remained a bright spot, the analyst tells investors in a research note. BrightView’s FY26 guide was below estimates as first-half is expected to be softer than the second half, the firm added.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BV:
- BrightView price target lowered to $10.50 from $13.50 at Goldman Sachs
- Mixed Outlook for BrightView Holdings: Hold Rating Maintained Amid Revenue Decline and Margin Strength
- BrightView price target lowered to $12 from $16 at Morgan Stanley
- BrightView price target lowered to $15 from $19 at Baird
- Optimistic Long-Term Growth Potential Despite Current Challenges: A ‘Show-Me’ Story